Get started
Author

Gordon S. Okawara

INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy
2002 · Bruce D. Minsky, Thomas F. Pajak, et al. · Journal of Clinical Oncology · 1,622
Phase II Trial of Preoperative Chemoradiation in Patients With Localized Gastric Adenocarcinoma (RTOG 9904): Quality of Combined Modality Therapy and Pathologic Response
2006 · Jaffer A. Ajani, Kathryn Winter, et al. · Journal of Clinical Oncology · 383
Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer
2001 · S. M. Lippman, J. J. Lee, et al. · JNCI Journal of the National Cancer Institute · 321
Randomized, Double-Blind, Placebo-Controlled, Phase III Chemoprevention Trial of Selenium Supplementation in Patients With Resected Stage I Non–Small-Cell Lung Cancer: ECOG 5597
2013 · Daniel D. Karp, Sandra J. Lee, et al. · Journal of Clinical Oncology · 132
PDF
Metformin in Combination With Chemoradiotherapy in Locally Advanced Non–Small Cell Lung Cancer
2021 · Theodoros Tsakiridis, Gregory R. Pond, et al. · JAMA Oncology · 117
PDF
Management of Unresected Stage III Non-small Cell Lung Cancer: A Systematic Review
2006 · Gordon Okawara, Jean A. Mackay, et al. · Journal of Thoracic Oncology · 71
PDF
Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline
2003 · Gordon Okawara, Yee Chung Ung, et al. · Lung Cancer · 48
Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non–Small-Cell Lung Cancer – Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial
2016 · Anand Swaminath, Marcin Wierzbicki, et al. · Clinical Lung Cancer · 46
Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non–Small Cell Lung Cancer
2024 · Anand Swaminath, Sameer Parpia, et al. · JAMA Oncology · 37
PDF
Longitudinal Quality-of-Life Analysis of RTOG 94-05 (Int 0123):A Phase III Trial of Definitive Chemoradiotherapy for Esophageal Cancer.
2011 · Lisa A Kachnic, Kathryn Winter, et al. · Europe PMC (PubMed Central) · 29
Genome-wide host methylation profiling of anal and cervical carcinoma
2021 · Erin M. Siegel, Abidemi Ajidahun, et al. · PLoS ONE · 24
PDF
Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials
2023 · Christopher L. Hallemeier, Jennifer Moughan, et al. · JAMA Network Open · 18
PDF
A phase III, intergroup, randomized, double-blind, chemoprevention trial of selenium (Se) supplementation in resected stage I non-small cell lung cancer (NSCLC).
2010 · D. D. Karp, S. J. Lee, et al. · Journal of Clinical Oncology · 18
Association of Phosphorylated Epidermal Growth Factor Receptor with Survival in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Radiotherapy
2008 · Theodoros Tsakiridis, Jean-Claude Cutz, et al. · Journal of Thoracic Oncology · 18
PDF
Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811
2016 · Corinne M. Doll, Jennifer Moughan, et al. · International Journal of Radiation Oncology*Biology*Physics · 16
Toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer: A secondary analysis of the LUSTRE randomized trial
2024 · Che Hsuan David Wu, Marcin Wierzbicki, et al. · Radiotherapy and Oncology · 13
PDF
A Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation for Patients With Non–Small-Cell Lung Cancer
2015 · Anand Swaminath, James R. Wright, et al. · Clinical Lung Cancer · 12
Early Occurrence of Angiosarcoma in a Woman With a BRCA2 Gene Variation of Unknown Significance Treated With Breast-Conserving Therapy for Bilateral Ductal Carcinoma: A Case Report
2015 · Elena Parvez, Snezana Popovic, et al. · Clinical Breast Cancer · 10
Predicting 2-Year Survival for Radiation Regimens in Advanced Non-small Cell Lung Cancer
2013 · W. Sharieff, G. Okawara, et al. · Clinical Oncology · 10
Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy
2024 · Fiorella Di Pastena, Gregory Pond, et al. · Radiation Oncology · 9
PDF
LUSTRE: A Phase III Randomized Trial of Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Hypofractionated Radiotherapy (CRT) for Medically Inoperable Stage I Non-Small Cell Lung Cancer (NSCLC)
2022 · A. Swaminath, S. Parpia, et al. · International Journal of Radiation Oncology*Biology*Physics · 9
MEDiastinal Irradiation and CArdio-Toxic Effects (MEDICATE): Exploring the Relationship between Cardiac Irradiation and High Sensitivity Troponins
2019 · E.K. Donovan, S. Dhesy-Thind, et al. · Clinical Oncology · 8
A phase II trial of preoperative chemotherapy and chemoradiotherapy for potentially resectable adenocarcinoma of the stomach (RTOG 99–04)
2005 · G. S. Okawara, K. Winter, et al. · Journal of Clinical Oncology · 8
Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
1997 · G Okawara, J Rusthoven, et al. · PubMed · 8
A Novel Neoadjuvant Therapy for Operable Locally Invasive Non–Small-Cell Lung Cancer. Phase I Study of Neoadjuvant Stereotactic Body Radiotherapy. LINNEARRE I (NCT02433574)
2017 · Nhu-Tram A. Nguyen, Naghmeh Isfahanian, et al. · Clinical Lung Cancer · 6
Works count: 54
Citation count: 3,006
H-index: 15
I10-index: 19
Year
Topic
Type